Search

everythinglearnresearchcommunity

for

Search:↓

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.

sPLA2-IIA increases growth in hair follicle stem cells and cancer cells, suggesting it could be targeted for hair growth and cancer treatment.

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.

Stress, nutritional issues, and chronic diseases can cause hair loss, and nail changes may signal internal diseases; treatment focuses on the underlying cause.

The document reviews 20 U.S. patents from July and August 2004 about new drug forms, cancer treatments, aroma chemicals, statin drugs, and various chemical production methods.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

Melanocytes produce melanin; their defects cause vitiligo and hair graying, with treatments available for vitiligo.

The meeting highlighted major advances in skin research, including new findings on skin microbes, genetic links to skin diseases, and improved treatments for various conditions.

The document says that hookworms are treated with mebendazole and stress-related hair loss usually gets better in 6 months, while other hair loss types have specific treatments.

New research has found 14 genes linked to the risk of developing alopecia areata, improving understanding and treatment options.

Patients with Systemic Sclerosis have much higher levels of GDF-15, which could help predict organ involvement and guide treatment.

Skin problems are common and early signs of Systemic Lupus Erythematosus, and certain immune system markers are important for diagnosis and treatment.

The 2006 editorial concluded that immunotherapy was advancing with new drugs, focusing on specific biological therapies and convenient oral treatments, and highlighted the importance of partnerships and new regulations in the field.

Oral and topical tofacitinib can help regrow hair in people with severe alopecia areata.

Topical JAK inhibitors may help children with alopecia areata regrow hair.

Blocking interferon-gamma might help treat various autoimmune diseases.

2-deoxy D-glucose does not help with hair regrowth in alopecia areata.

Clofazimine effectively treated a rare skin condition with ash-gray patches.

A boy with a rare birthmark called verrucous hemangioma needed careful timing for surgery due to its size and depth.

Clofazimine may be effective for treating ashy dermatosis.

JAK inhibitors can effectively reverse hair loss in people with alopecia areata.

A medication for skin rash also unexpectedly treated hair loss in a patient.

Mesalazine may help treat extensive alopecia areata effectively.

New treatments for the autoimmune hair loss condition alopecia areata may include JAK inhibitors and other immunomodulators.

The treatment showed significant hair regrowth in alopecia areata patients without side effects.

Light-based therapies show promise as safe treatments for hair loss.

Topical tofacitinib is effective and safe for treating alopecia areata.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

Contact sensitizers like DCP and SADBE are the most effective treatments for alopecia areata.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.